NYSCF congratulates Marius Wernig, MD, PhD, for receiving the 2018 Ogawa-Yamanaka Stem Cell Prize from the Gladstone Institutes for his work in cellular reprogramming and stem...
New collaboration aims to develop better therapies New York, NY (August 1, 2018) – The New York Stem Cell Foundation (NYSCF) Research Institute today announced a...
Protocol adds a new cell type enabling myelination in human ‘mini-brains’ for laboratory research New York, NY (July 25, 2018) – In a collaborative study between...
Last week, the annual meeting of the International Society for Stem Cell Research (ISSCR) convened over 3500 participants in Melbourne, Australia to share the latest advances...
Researchers at the California Institute of Technology led by NYSCF – Robertson Investigator Mitchell Guttman, PhD, have developed a new tool called SPRITE to uncover how...
According to a new study from NYSCF – Robertson Investigator Alumnus and NYSCF – Robertson Stem Cell Prize recipient Marius Wernig, MD, PhD, Associate Professor in the Institute...
This week, NYSCF hosted a panel discussion with the Johns Hopkins University Berman Institute for Bioethics to discuss a growing issue: stem cell tourism. “Stem cell...
Over the past 20 years, embryonic stem cell (ESC) research has evolved from a brand new field with lots of promise to one that is actively...
Thanks to a groundbreaking new stem cell treatment, patients with age-related macular degeneration (AMD) are getting their sight back. This treatment was pioneered by the inaugural...
Before a motor neuron can become a motor neuron, it has to undergo some important changes. One of these changes happens through a process called methylation....
NYSCF — Robertson Stem Cell Investigator Sergiu Pasca’s lab at Stanford University has been at the forefront of the new field of brain organoids and has...
The heart is made of muscle, and for it to function properly, that muscle has to be strong and durable. A condition called left ventricular non-compaction...
With a background in pharmacology, drug discovery, and research and development strategy, in addition to extensive experience in both industry and academia, Liz will expand NYSCF’s...
Schizophrenia is often studied by analyzing the brains of patients after they’ve passed away. These types of studies usually contain small sample sizes and focus on...
As we enter 2018, NYSCF is taking a moment to look back on the milestones of 2017. With your support, we accelerated our research, began new...
The Scientist magazine recently named their top 6 technical advances of 2017, and their list included 3 discoveries pioneered by NYSCF Investigators. The first advancement was...
The Dana Foundation attended NYSCF’s recent talk, Unlocking the Diseases of the Brain with Stem Cells,” at NYSCF headquarters in Manhattan. The talk featured a panel...
NYSCF – Robertson Stem Cell Investigator Takanori Takebe, MD, of Cincinnati Children’s Hospital and Yokohama City University in Japan, led a study demonstrating a successful system for...
NYSCF Research Institute scientists in collaboration with researchers at the Icahn School of Medicine at Mount Sinai refined a technique to turn skin cells from patients...
NYSCF welcomed six of the most talented stem cell researchers and neuroscientists from around the world into the NYSCF Investigator Program and the NYSCF Innovator Community....
Dr. Paul Tesar, a professor at Case Western Reserve University and NYSCF — Robertson Stem Cell Investigator Alumnus, is the 2017 recipient of the NYSCF –...
NYSCF and the Beyond Batten Disease Foundation (BBDF) partnered to create a unique and comprehensive collection of juvenile Batten (CLN3) disease induced pluripotent stem (iPS) cells....
NYSCF – Robertson Stem Cell Investigator Dr. Malin Parmar, a Professor at Lund University in Sweden, published a flurry of papers this summer all describing exciting...
The Food and Drug Administration (FDA) announced an increase in oversight and enforcement of the use of unproven stem cell therapies in the US. Hundreds of...
NYSCF – Robertson Stem Cell Investigator Alumna Dr. Shuibing Chen at Weill Cornell Medical School successfully developed a protocol for deriving organoids representing the human digestive...
